Search clinical trials for: CYPHER Sirolimus-eluting Coronary Stent

Total 710 results

Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Cordis Corporation

Unknown

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)

Coronary Artery Disease | Coronary Atherosclerosis

United States
Brighton and Sussex University Hospitals NHS Trust
Abbott Medical Devices

Completed

Xience or Vision Stent Management of Angina in the Elderly (XIMA)

Coronary Artery Disease

United Kingdom
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) (PROTECT)

Ischemic Heart Disease

Netherlands
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Patients With Coronary Artery Disease (CAD) (RACES)

Coronary Artery Disease | Coronary Atherosclerosis

Italy
Odense University Hospital

Completed

Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Stent Implantation (OCTACS)

Myocardial Infarction | Coronary Artery Disease
Aarhus University Hospital Skejby
Odense University Hospital; University of Copenhagen; University of Aarhus

Completed

Comparison of Cypher Select and Taxus Express Coronary Stents (SORT-OUTII)

Coronary Artery Disease | Angina Pectoris
Charite University, Berlin, Germany
Techniker Krankenkasse

Completed

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents (GERSHWIN)

Coronary Artery Disease

Germany
Sunil Rao
Cordis Corporation

Completed

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Coronary Occlusions

United States, Canada
Cordis Corporation

Completed

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Coronary Artery Disease

United States
Odense University Hospital

Completed

The SOURT OUT IV TRIAL (SORT OUT IV)

Ischemic Heart Disease | Percutaneous Coronary Intervention | Coronary Atherosclerosis

Denmark
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors Europe SA

Unknown

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII (SORT-OUT VIII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Cordis Corporation

Completed

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (TROPICAL)

Coronary Artery Disease

Belgium, Germany
Hyogo College of Medicine

Withdrawn

Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents (ASSESS)

Coronary Artery Disease | Atherosclerosis

Japan
Cordis Corporation

Completed

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
Deutsches Herzzentrum Muenchen

Completed

3 Limus Agent Eluting Stents With Different Polymer Coating (ISAR-TEST-4)

Coronary Heart Disease

Germany
Seung-Jung Park
Medtronic; CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV) (LONG-DES-IV)

Coronary Artery Disease

Korea, Republic of
Catholic University of the Sacred Heart

Completed

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (Z-SEA-SIDE)

Coronary Artery Disease | Coronary Stenosis

Italy
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Deutsches Herzzentrum Muenchen

Unknown

Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography (PPS/PFS-OCT)

Coronary Heart Disease

Germany
Catholic University of the Sacred Heart

Completed

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (SEA-SIDE)

Coronary Artery Disease | Coronary Stenosis

Italy
Aarhus University Hospital Skejby
Medtronic Cardiovascular; Biosensors International

Completed

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® (SO VI)

Coronary Artery Disease | Angina Pectoris

Denmark
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
A.O. Ospedale Papa Giovanni XXIII
Medtronic; Case Western Reserve University

Completed

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography (OCTAMI)

Acute Myocardial Infarction

Italy
Russian Academy of Medical Sciences
Medtronic

Unknown

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (ZES for STEMI)

ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Russian Federation
Odense University Hospital

Unknown

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent (SORT OUT VII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Cordis Corporation

Completed

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Coronary Artery Disease
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) (LONG-DES-III)

Coronary Artery Disease

Korea, Republic of
Catharina Ziekenhuis Eindhoven
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Compusense... and other collaborators

Completed

Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction (DEBATER)

Acute Myocardial Infarction

Netherlands
Medtronic Bakken Research Center

Completed

E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent (eFive)

Coronary Artery Disease
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions (ISAR-CABG)

Arteriosclerosis of Arterial Coronary Artery Bypass Graft

Germany
Royal Brompton & Harefield NHS Foundation Trust

Completed

A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents (ORCA-2)

Coronary Artery Disease

United Kingdom
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Biotronik AG

Completed

First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions (BIOFLOW-I)

Coronary Artery Disease

Romania
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
Vulnerable Plaque Society

Completed

Treatment of Bifurcation Lesions by SINGLE STENT and KISSing Balloon Trial (SINGLEKISS)

Ischemic Heart Disease | Restenosis

Japan
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
Meril Life Sciences Pvt. Ltd.
Lifecare Institute of Medical Sciences and Research Ahmedabad Gujarat India

Completed

Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions (meriT-1)

Coronary Artery Disease

India
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)

Coronary Artery Disease

Japan
Medtronic Vascular

Completed

Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries. (ENDEAVORSVS)

Coronary Artery Disease

United States
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) (RENASCENT III)

Myocardial Ischemia | Coronary Artery Disease

Italy, Colombia

Search clinical trials for: CYPHER Sirolimus-eluting Coronary Stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations